Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View

 

Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View

2014-11-13 14:42:27| Biotech - Topix.net

Until Merck's product can deliver an optimal cure rate at a cheaper price, it poses no threat to Gilead's Harvoni. Merck's attempt to compete with Gilead in finding a cure for hepatitis C has fallen short .

Tags: view rate rear cure

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

05.10 Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories 05.10 Hurricane Kirk Graphics 05.10 Hurricane Kirk Forecast Discussion Number 24 05.10 Hurricane Kirk Wind Speed Probabilities Number 24 05.10 Hurricane Kirk Forecast Advisory Number 24 05.10 Hurricane Kirk Public Advisory Number 24 05.10 Summary for Hurricane Kirk (AT2/AL122024) 05.10 Hurricane Leslie Graphics More »